Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-07-28

FDA Approved: NADOLOL — Original Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved Nadolol as a generic drug in an Original Application (ANDA) for Zydus Pharmaceuticals USA Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nadolol (Nadolol)

Snippet

ORIG AP for NADOLOL (NADOLOL)